# US 2009/0264662 A1 · PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0264662 A1
- Document ID: US20090264662A1
- Status: Published application
- Kind: A1
- Application number: 11/571,825
- Filed: 2005-07-06
- Published: 2009-10-22
- Earliest claimed: 2004-07-09
- Assignees: FDC Limited
- Inventors: Anand Mohan Chandavarkar; Rajaram Uday Bapat; Anand Atul Bade; Anand Pandurang Chavan
- Web page: https://patentgrep.com/patent/US20090264662A1

## CPC

- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to resolution of (cis, trans) 5,6-dihydro-4H-4-ethylamino-6-methylthieno[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide using dibenzoyl-L-tartaric acid monohydrate or di-p-toluoyl-L-tarrtaric acid monohydrate as a chiral resolving agent in presence of methanol to obtain hemitartarate salt, purifying it to obtain hemitartarate salt of 5,6-dihydro-4 H-4 (S)-ethyl amino-6(S) methylthieno [2,3-b] thiopyran-2-sulfonamide-7,7-dioxide with de of >99% , Chemical purity >99.5% with cis isomer content of <0.1% and further converting into its pharmaceutically acceptable salts, preferably hydrochloride salt.

## Claims

### Claim at position 1

1-7. (canceled)

### Claim 8

An improved process for the preparation of 5,6-dihydro-4H-4(S)-ethylamino-6(S) methylthieno [2,3-b] thiopyran-2-sulfonamide-7,7-dioxide hydrochloride comprising of:
a. contacting (cis, trans) 5,6-dihydro-4H-4-ethylamino-6-methylthieno [2,3-b] thiopyran-2-sulfonamide-7,7-dioxide with di-O-substituted-L-tartaric acid in an organic solvent to obtain intermediate hemitartarate salt of formula IV,
b. refluxing the hemitartarate salt with methanol to obtain pure hemitartarate salt,
c. treating the purified hemitartarate salt with ethylacetate and an aqueous alkali carbonate solution, separating ethylacetate and aqueous layer,
d. extracting the aqueous layer with ethylacetate, separating the ethylacetate layer,
e. combining ethylacetate layers of (d) and (e), washing with water, collecting water washed ethylacetate layer to obtain 5,6-dihydro-4H-4(S)-ethylamino-6(S) methylthieno [2,3-b] thiopyran-2-sulfonamide-7,7-dioxide,
f. adjusting pH of ethylacetate layer between 1.0 and 2.0 with isopropanol-hydrochloric acid solution, and
g. separating the precipitated solid and crystallizing from isopropanol.

### Claim 9 (depends on 8)

A process of claim 8, wherein the organic solvent used is methanol.

### Claim 10 (depends on 8)

A process of claim 8, wherein di-O-substituted L-tartaric acid used, is selected from a group consisting of di-O-benzoyl-L-tartaric acid monohydrate and di-O-p-toluoyl-L-tartaric acid monohydrate.

### Claim 11 (depends on 8)

A process of claim 8, wherein the di-O-substituted-L-tartaric acid used is preferably di-O-benzoyl-L-tartaric acid monohydrate.

### Claim 12 (depends on 8)

A process of claim 8, wherein the aqueous alkali carbonate solution is selected from the group consisting of aqueous potassium carbonate and aqueous sodium carbonate solution.

### Claim 13 (depends on 8)

A process of claim 8 wherein the preferred alkali carbonate solution is aqueous sodium carbonate solution.
